Torsten Haferlach

57PUBLICATIONS
342CO-AUTHORS
Medical mycologyGene and molecular therapyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Jul 13, 2026
Subclonal MECOM rearrangements in myeloid neoplasms: enriched for TP53 mutations and adverse outcome.

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Jun 08, 2026
Comprehensive landscape of secondary cytogenetic and molecular genetic events in multiple myeloma patients at diagnosis.

|May 09, 2026
The clinical relevance of sole loss of chromosome Y in myeloid neoplasms.

|Mar 25, 2026
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma.

Johannes Waldschmidt, David Fandrei, Judith S Hecker

|Mar 19, 2026
Multiple myeloma with concomitant chronic lymphocytic leukemia: evidence for independent clonal origin.

Jana Wobst, Henning Ruge, Sara Senk

Pageof 10

Frequent Collaborators

24 joint publications

Claudia Haferlach

19 joint publications

Manja Meggendorfer

19 joint publications

Wolfgang Kern

15 joint publications

Wencke Walter